Baxter International Inc.

Baxter Healthcare Sa

Andreas Goessl

Cary J Reich

Heinz Gulle

Atsushi Edward Osawa

Monika Mangold

Melitta Bilban

John J Barry

Katarzyna Gorna

Joris Hoefinghoff

Katarzyna I Gorna

Gerald Zimmer

Described is a process for making a dry and stable hemostatic composition, said process comprising

Process for making dry and stable hemostatic compositions

The invention discloses a hemostatic composition comprising:

Hemostatic compositions

The invention discloses a pharmaceutical hemostatic liquid foam base preparation comprising albumin as foaming agent and a fibrinogen precipitating substance and optionally a coagulation inducing agent, wherein albumin as foaming agent is present in native form; a method for the production of a transient hemostatic liquid foam; the transient hemostatic liquid foam; and a kit for making the foam.

Hemostatic foam

The present invention relates to a biodegradable injectable composition for bone augmentation comprising fibrin, a contrast agent and calcium salt-containing particles, as well as a method for bone augmentation in a patient suffering from a bone disorder comprising injecting said composition into a non-mineralized or hollow portion of said bone.

Injectable fibrin composition for bone augmentation

Bone hemostat compositions, and methods for their use and manufacture are provided. Exemplary hemostatic compositions include polymeric components such as random and non-random copolymers, natural polymers, ceramics, reactive group polymers, and combinations thereof. Bone compositions may be used during surgical procedures, and may be applied to bone to inhibit or prevent bleeding from bone.

Aqueous compositions and methods for bone hemostasis

The present invention teaches a micro-porous injectable, soft elastic, fully resorbable fibrin-based composition for use as a soft tissue lumen and void filler. The composition of the present application exhibits physical characteristics, such as mechanical properties, typically seen in elastomers and mechanical stability, which is superior to fibrin alone. A variety of properties of the composition of the present invention can be effectively fine-tuned and altered by adjusting type and content of the particles as well as of the plasticizer contained in the void filler composition.

Injectable void filler for soft tissue augmentation

The present invention relates to a biodegradable fibrin based composition for injection into osseous defects or voids, which can be the result of osteoporosis, surgery, bone cysts, tumor removal or traumatic bone injury.

Growing community of inventors

Vienna, Austria

Andreas Goessl